PPD® Biotech is a Phase I-IV contract research organization (CRO) service provider devoted to biotech and small to midsize pharma companies.
Expertise in nearly 40 psychiatric and neurological disorders, and clinically trained neuroscience teams led by scientists and clinicians with extensive neuroscience experience.
As clinical trial investigators, physicians play an integral role in the development of life-changing medicines.
View all of PPD's news releases.
Stephen Peroutka, vice president and therapeutic area head in neuroscience, shares his thoughts on the importance and outlook of conducting clinical trials for Alzheimer’s disease.
Regulatory affairs experts at PPD, Alistair Davidson and Vincenzo Cannizzaro, reflect on how the United Kingdom's departure from the European Union might impact the pharmaceutical industry.
Bill Wang, director of regulatory affairs, discusses China's regulatory environment in the second-largest pharmaceutical market in the world.
Derek Wood, an associate director for PPD® Laboratories GMP Lab, discusses the growth of extractables and leachables in the required testing for pharmaceutical products.
Michael Gawkins, a director in technology, innovation and performance, advances ideas about the role of innovation in teams.
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.